ABVX
Price
$113.32
Change
+$22.71 (+25.06%)
Updated
Feb 3 closing price
Capitalization
8.81B
47 days until earnings call
Intraday BUY SELL Signals
KPRX
Price
$2.26
Change
-$0.56 (-19.86%)
Updated
Feb 3 closing price
Capitalization
8.72M
Intraday BUY SELL Signals
Interact to see
Advertisement

ABVX vs KPRX

Header iconABVX vs KPRX Comparison
Open Charts ABVX vs KPRXBanner chart's image
Abivax SA
Price$113.32
Change+$22.71 (+25.06%)
Volume$733.97K
Capitalization8.81B
Kiora Pharmaceuticals
Price$2.26
Change-$0.56 (-19.86%)
Volume$98.72K
Capitalization8.72M
ABVX vs KPRX Comparison Chart in %
ABVX
Daily Signal:
Gain/Loss:
KPRX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ABVX vs. KPRX commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABVX is a Hold and KPRX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (ABVX: $111.46 vs. KPRX: $2.34)
Brand notoriety: ABVX and KPRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABVX: 42% vs. KPRX: 93%
Market capitalization -- ABVX: $8.81B vs. KPRX: $8.72M
ABVX [@Biotechnology] is valued at $8.81B. KPRX’s [@Biotechnology] market capitalization is $8.72M. The market cap for tickers in the [@Biotechnology] industry ranges from $119.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABVX’s FA Score shows that 0 FA rating(s) are green whileKPRX’s FA Score has 1 green FA rating(s).

  • ABVX’s FA Score: 0 green, 5 red.
  • KPRX’s FA Score: 1 green, 4 red.
According to our system of comparison, KPRX is a better buy in the long-term than ABVX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABVX’s TA Score shows that 3 TA indicator(s) are bullish while KPRX’s TA Score has 6 bullish TA indicator(s).

  • ABVX’s TA Score: 3 bullish, 6 bearish.
  • KPRX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, KPRX is a better buy in the short-term than ABVX.

Price Growth

ABVX (@Biotechnology) experienced а -7.79% price change this week, while KPRX (@Biotechnology) price change was +11.43% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.27%. For the same industry, the average monthly price growth was +3.31%, and the average quarterly price growth was +36.66%.

Reported Earning Dates

ABVX is expected to report earnings on Mar 23, 2026.

Industries' Descriptions

@Biotechnology (-4.27% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABVX($8.81B) has a higher market cap than KPRX($8.72M). KPRX YTD gains are higher at: 18.782 vs. ABVX (-17.348). KPRX has higher annual earnings (EBITDA): -9.21M vs. ABVX (-170.04M). ABVX has more cash in the bank: 104M vs. KPRX (19.4M). KPRX has less debt than ABVX: KPRX (404K) vs ABVX (92.6M). ABVX (0) and KPRX (0) have equivalent revenues.
ABVXKPRXABVX / KPRX
Capitalization8.81B8.72M101,078%
EBITDA-170.04M-9.21M1,845%
Gain YTD-17.34818.782-92%
P/E RatioN/A3.67-
Revenue00-
Total Cash104M19.4M536%
Total Debt92.6M404K22,921%
FUNDAMENTALS RATINGS
KPRX: Fundamental Ratings
KPRX
OUTLOOK RATING
1..100
83
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
53
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
47

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABVXKPRX
RSI
ODDS (%)
Bearish Trend 6 days ago
71%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
68%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 13 days ago
89%
Bullish Trend 5 days ago
78%
Declines
ODDS (%)
Bearish Trend 5 days ago
79%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ABVX
Daily Signal:
Gain/Loss:
KPRX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PLAY20.081.31
+6.98%
Dave & Buster's Entertainment
WHWK2.880.18
+6.67%
Whitehawk Therapeutics Inc
FLEX64.681.64
+2.60%
Flex Ltd
TTAM17.710.35
+2.02%
Titan America SA
AKTX0.24N/A
+1.02%
Akari Therapeutics plc

ABVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABVX has been loosely correlated with NEVPF. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if ABVX jumps, then NEVPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABVX
1D Price
Change %
ABVX100%
+0.28%
NEVPF - ABVX
65%
Loosely correlated
N/A
IMNN - ABVX
58%
Loosely correlated
-4.22%
ANEB - ABVX
49%
Loosely correlated
-8.84%
CGON - ABVX
38%
Loosely correlated
+4.40%
XENE - ABVX
38%
Loosely correlated
+1.07%
More

KPRX and

Correlation & Price change

A.I.dvisor tells us that KPRX and PGEN have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KPRX and PGEN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KPRX
1D Price
Change %
KPRX100%
-2.50%
PGEN - KPRX
33%
Poorly correlated
+7.57%
SYRE - KPRX
32%
Poorly correlated
+2.41%
ABVX - KPRX
31%
Poorly correlated
+0.28%
AKTX - KPRX
30%
Poorly correlated
+1.02%
MTVA - KPRX
30%
Poorly correlated
-4.94%
More